{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:05:48Z","timestamp":1790928348125,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["30204"],"award-info":[{"award-number":["30204"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ctrv.2025.103051","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:56:10Z","timestamp":1763646970000},"page":"103051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bone metastases in NSCLC: Modern paradigms in management and supportive care"],"prefix":"10.1016","volume":"142","author":[{"given":"Gabriele","family":"Minuti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Pasqualini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Avancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Colonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Di","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Montrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Olmetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pastorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lucia","family":"Reale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Teresa","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Sini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viscardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pilotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0005","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.21037\/jtd-21-1502","article-title":"Bone metastases in non-small cell lung cancer: a narrative review","volume":"14","author":"Knapp","year":"2022","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0010","first-page":"321","article-title":"Bone Metastases: An Overview","volume":"11","author":"Macedo","year":"2017","journal-title":"Oncol Rev"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103051_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126832","article-title":"Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications","volume":"23","author":"Del Conte","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0020","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/mco.2017.1394","article-title":"Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis","volume":"7","author":"Tominaga","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103051_b0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.21037\/tlcr.2019.08.16","article-title":"Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study","volume":"8","author":"Zheng","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ctrv.2025.103051_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108531","article-title":"Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study","volume":"203","author":"Avancini","year":"2025","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379056","article-title":"Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer","volume":"15","author":"Abbott","year":"2024","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5306\/wjco.v15.i6.765","article-title":"What enlightenment has the development of lung cancer bone metastasis brought in the last 22 years","volume":"15","author":"Chen","year":"2024","journal-title":"World J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0050","article-title":"Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib","volume":"4","author":"Brouns","year":"2023","journal-title":"JTO Clin Res Rep"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s40425-019-0793-8","article-title":"Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer","volume":"7","author":"Landi","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103051_b0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jso.25114","article-title":"PET imaging for assessing tumor response to therapy","volume":"118","author":"Mankoff","year":"2018","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103051_b0065","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO Clinical Practice Guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0070","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1038\/srep18670","article-title":"Natural History of Non-Small-Cell Lung Cancer with Bone Metastases","volume":"5","author":"Santini","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103051_b0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JTO.0000000000000051","article-title":"Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13","volume":"9","author":"Katakami","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.7150\/jca.1.80","article-title":"Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST","volume":"1","author":"Costelloe","year":"2010","journal-title":"J Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0085","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00432-022-04120-z","article-title":"Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients","volume":"149","author":"De Giglio","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103051_b0090","first-page":"1157","article-title":"Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents","volume":"23","author":"Patrick","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12885-021-07903-8","article-title":"Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95\/16)","volume":"21","author":"Ribi","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103051_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000689","article-title":"Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome","volume":"5","author":"Trestini","year":"2020","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103051_b0105","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2011.10.009","article-title":"Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer","volume":"76","author":"Jones","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctrv.2025.103051_b0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12955-016-0461-3","article-title":"Impact of self-reported physical activity and health promotion behaviors on lung cancer survivorship","volume":"14","author":"Sloan","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctrv.2025.103051_b0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2018.01.004","article-title":"Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers","volume":"108","author":"Chambard","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.ctrv.2025.103051_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.603936","article-title":"Nutritional Risk Screening in Cancer Patients: The First Step Toward Better Clinical Outcome","volume":"8","author":"Reber","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.ctrv.2025.103051_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12874-015-0045-7","article-title":"The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review","volume":"15","author":"Amireault","year":"2015","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.ctrv.2025.103051_b0130","doi-asserted-by":"crossref","first-page":"004","DOI":"10.1016\/j.jbo.2018.10.004","article-title":"Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management","volume":"15","author":"D'Oronzo","year":"2019","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2017.10.010","article-title":"The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review","volume":"62","author":"de Groot","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103051_b0140","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103051_b0145","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103051_b0150","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","article-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study","volume":"7","author":"Scagliotti","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2025.103051_b0155","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2020.06.011","volume":"15","author":"Peters","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11096-020-01105-1","article-title":"Meta-analysis of clinical trials to assess denosumab over zoledronic acid in bone metastasis","volume":"43","author":"Chen","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.ctrv.2025.103051_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100416","article-title":"Experience with denosumab (XGEVA(R)) for prevention of skeletal-related events in the 10 years after approval","volume":"33","author":"Cadieux","year":"2022","journal-title":"J Bone Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103051_b0170","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41571-018-0095-y","article-title":"Roles of the RANKL-RANK axis in antitumour immunity - implications for therapy","volume":"15","author":"Ahern","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0175","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1431088","article-title":"RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer","volume":"7","author":"Ahern","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctrv.2025.103051_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697298","article-title":"Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio","volume":"12","author":"Bongiovanni","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctrv.2025.103051_b0185","article-title":"Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103051_b0190","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.ctrv.2025.103051_b0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ctrv.2018.05.013","article-title":"The Dutch national guideline on metastases and hematological malignancies localized within the spine; a multidisciplinary collaboration towards timely and proactive management","volume":"69","author":"Groenen","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"25","key":"10.1016\/j.ctrv.2025.103051_b0200","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0205","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.21.01719","article-title":"Practical Management of Oligometastatic Non-Small-Cell Lung Cancer","volume":"40","author":"Jasper","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0210","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.ctrv.2025.103051_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215234","article-title":"Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials","volume":"15","author":"Izmailov","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103051_b0220","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.21037\/tlcr-21-265","article-title":"Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review","volume":"10","author":"Mentink","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"16","key":"10.1016\/j.ctrv.2025.103051_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163977","article-title":"Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer","volume":"14","author":"Santos","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10185","key":"10.1016\/j.ctrv.2025.103051_b0230","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103051_b0235","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ijrobp.2022.06.067","article-title":"Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO\/EORTC Nomenclature","volume":"114","author":"Nevens","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103051_b0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","article-title":"Update of the systematic review of palliative radiation therapy fractionation for bone metastases","volume":"126","author":"Rich","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.23.00753","article-title":"Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial","volume":"42","author":"Gillespie","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100519","article-title":"Incidence and radiotherapy treatment patterns of complicated bone metastases","volume":"44","author":"Peters","year":"2024","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2019.01.019","article-title":"Single versus multifraction radiotherapy for spinal cord compression: A systematic review and meta-analysis","volume":"134","author":"Donovan","year":"2019","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103051_b0260","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","volume":"22","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0265","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","article-title":"Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial","volume":"5","author":"Nguyen","year":"2019","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103051_b0270","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.55409","article-title":"Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis","volume":"7","author":"Bindels","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbo.2014.11.001","article-title":"Quality of life after palliative radiotherapy in bone metastases: A literature review","volume":"4","author":"McDonald","year":"2015","journal-title":"J Bone Oncol"},{"issue":"27","key":"10.1016\/j.ctrv.2025.103051_b0280","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0285","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ijrobp.2023.12.045","article-title":"Meta-Analysis of Stereotactic Body Radiation ThERapy in Nonspine BONE Metastases (MASTER-BONES)","volume":"119","author":"Moraes","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0290","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13014-019-1379-9","article-title":"Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system","volume":"14","author":"Giaj-Levra","year":"2019","journal-title":"Radiat Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0295","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","article-title":"The NOMS framework: approach to the treatment of spinal metastatic tumors","volume":"18","author":"Laufer","year":"2013","journal-title":"Oncologist"},{"issue":"9486","key":"10.1016\/j.ctrv.2025.103051_b0300","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijrobp.2011.10.080","article-title":"Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis","volume":"84","author":"Huisman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0310","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jor.24660","article-title":"Fracture risk assessment and clinical decision making for patients with metastatic bone disease","volume":"38","author":"Damron","year":"2020","journal-title":"J Orthop Res"},{"issue":"Suppl 3","key":"10.1016\/j.ctrv.2025.103051_b0315","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2009.0076","article-title":"NCCN Task Force Report: Bone Health in Cancer Care","volume":"7","author":"Gralow","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ctrv.2025.103051_b0320","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1302\/2058-5241.1.000008","article-title":"Treatment of pathological fractures of the long bones","volume":"1","author":"Willeumier","year":"2016","journal-title":"EFORT Open Rev"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103051_b0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10147-005-0478-9","article-title":"Surgical treatment of bone metastasis: indications and outcomes","volume":"10","author":"Manabe","year":"2005","journal-title":"Int J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ctrv.2025.103051_b0335","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","article-title":"Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group","volume":"29","author":"Fourney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-717X-9-69","article-title":"Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases","volume":"9","author":"Fisher","year":"2014","journal-title":"Radiat Oncol"},{"issue":"Supplement_1","key":"10.1016\/j.ctrv.2025.103051_b0345","doi-asserted-by":"crossref","first-page":"i25","DOI":"10.1093\/nop\/npaa056","article-title":"The importance of multidisciplinary care for spine metastases: initial tumor management","volume":"7","author":"Newman","year":"2020","journal-title":"Neuro-Oncol Pract"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0350","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 4","key":"10.1016\/j.ctrv.2025.103051_b0355","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1156618","article-title":"Management of pain in patients with bone metastases","volume":"13","author":"Jing","year":"2023","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103051_b0365","first-page":"e3286","article-title":"Pain Management in Metastatic Bone Disease: A Literature Review","volume":"10","author":"Ahmad","year":"2018","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0370","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/advances\/nmac070","article-title":"Current Insights in Nutrition Assessment and Intervention for Malnutrition or Muscle Loss in People with Lung Cancer: A Narrative Review","volume":"13","author":"Kiss","year":"2022","journal-title":"Adv Nutr"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103051_b0375","doi-asserted-by":"crossref","first-page":"e584","DOI":"10.1016\/j.cllc.2020.10.008","article-title":"Nutritional Support in Lung Cancer Patients: The State of the Art","volume":"22","author":"Mele","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0380","first-page":"389","article-title":"Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis","volume":"28","author":"Dohzono","year":"2020","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0385","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/jso.26793","article-title":"Body composition predictors of mortality in patients undergoing surgery for long bone metastases","volume":"125","author":"Groot","year":"2022","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103051_b0390","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0395","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0400","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz080","article-title":"Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis","volume":"4","author":"Friedenreich","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.ctrv.2025.103051_b0405","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2502760","article-title":"Structured Exercise after Adjuvant Chemotherapy for Colon Cancer","author":"Courneya","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103051_b0410","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/jcsm.13568","article-title":"Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study","volume":"15","author":"Trestini","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ctrv.2025.103051_b0415","article-title":"Effect of exercise for patients with advanced lung cancer and cancer-related fatigue: A systematic review and meta-analysis","volume":"14","author":"Hu","year":"2024","journal-title":"J Sport Health Sci"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103051_b0420","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14737140.2022.2082410","article-title":"Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer","volume":"22","author":"Avancini","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ctrv.2025.103051_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103433","article-title":"Exercise for individuals with bone metastases: A systematic review","volume":"166","author":"Weller","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103051_b0430","article-title":"A Physical Exercise Intervention, Delivered Through In-Person or Home-Based Programs, in Patients Living With Cancer and Bone Metastases: A Single-Arm, Feasibility Study","volume":"2025","author":"Borsati","year":"2025","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103051_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42768","article-title":"Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report","volume":"11","author":"Borsati","year":"2025","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0440","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamaoncol.2019.0011","article-title":"Effect of Collaborative Telerehabilitation on Functional Impairment and Pain Among Patients With Advanced-Stage Cancer: A Randomized Clinical Trial","volume":"5","author":"Cheville","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ctrv.2025.103051_b0445","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-025-07645-4","article-title":"Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis","author":"Borsati","year":"2025","journal-title":"Osteoporosis Int"},{"issue":"24","key":"10.1016\/j.ctrv.2025.103051_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246078","article-title":"Exercise and Bone Health in Cancer: Enemy or Ally?","volume":"14","author":"Avancini","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103051_b0455","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111771","article-title":"Paravertebral Muscle Training in Patients with Unstable Spinal Metastases Receiving Palliative Radiotherapy: An Exploratory Randomized Feasibility Trial","volume":"11","author":"Sprave","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctrv.2025.103051_b0460","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-14-67","article-title":"Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial","volume":"14","author":"Rief","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctrv.2025.103051_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104718","article-title":"Physical activity guidelines in oncology: A systematic review of the current recommendations","volume":"210","author":"Avancini","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0470","doi-asserted-by":"crossref","first-page":"e697","DOI":"10.1200\/OP.21.00454","article-title":"Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals","volume":"18","author":"Campbell","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103051_b0475","first-page":"2175","article-title":"Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany","volume":"28","author":"Link","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ctrv.2025.103051_b0480","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.588862","article-title":"High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases","volume":"10","author":"Lagana","year":"2020","journal-title":"Front Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225001732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225001732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:02:57Z","timestamp":1767168177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737225001732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":96,"alternative-id":["S0305737225001732"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103051","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metastases in NSCLC: Modern paradigms in management and supportive care","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103051"}}